Strategic Blueprint, LLC Moderna, Inc. Transaction History

Strategic Blueprint, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$101.21 - $166.61 $3,744 - $6,164	-37 Reduced 1.67%	2,175 $258,000
Q1 2024 Apr 23, 2024	SELL	$85.37 - $115.44 $682 - $923	-8 Reduced 0.36%	2,212 $235,000
Q4 2023 Jan 25, 2024	SELL	$69.51 - $104.43 $11,538 - $17,335	-166 Reduced 6.96%	2,220 $220,000
Q3 2023 Oct 18, 2023	BUY	$96.41 - $126.61 $54,182 - $71,154	562 Added 30.81%	2,386 $246,000
Q2 2023 Oct 18, 2023	BUY	$118.5 - $160.53 $216,144 - $292,806	1,824 New	1,824 $221,000
Q4 2022 Jan 26, 2023	BUY	$118.38 - $210.04 $137,675 - $244,276	1,163 New	1,163 $0
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $139,150 - $209,788	-1,188 Closed	0 $0
Q1 2022 Aug 12, 2022	BUY	$126.46 - $235.05 $150,234 - $279,239	1,188 New	1,188 $205,000
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $7,100 - $15,503	-32 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $4,157 - $7,519	32 New	32 $7,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Blueprint, LLC with notifications on news.